163
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Economic Analysis 20 Years after the Introduction of Universal HBV Immunisation in Bulgaria

, , , &
Pages 2811-2816 | Published online: 16 Apr 2014

REFERENCES

  • Andre F.E., Booy R., Bock H.L., Clemens J., Datta S.K., John T.J., Lee B.W., Lolekha S., Peltola H., Ruff T.A., Santosham M., Schmitt H.J. (2008) Bulletin of the World Health Organization, 86, 140–146.
  • Beutels P. (2001) Health Econ., 10(8), 751–774.
  • Beutels P., Edmunds W.J., Antoñanzas F., de Wit G.A., Evans D., Feilden R., Fendrick A.M., Ginsberg G.M., Glick H.A., Mast E., Péchevis M., van Doorslaer E.K.A., van Hout B.A. (2002) PharmacoEconomics, 20(1), 1–7.
  • Bloom B.S., Hillman A.L., Fendrick A.M., Schwartz J.S. (1993) Ann. Intern. Med., 118, 298–306.
  • Drummond M., Chevat C., Lothgren M. (2007) Vaccine, 25, 5945–5957.
  • Ehreth J. (2003) Vaccine, 21, 4112.
  • Goldstein S.T., Alter M.J., Williams I.T., Moyer L.A., Judson F.N., Mottram K., Fleenor M., Ryder P.L., Margolis H.S. (2002) J. Infect. Dis., 185, 713–719.
  • Jacobs R.J., Meyerhoff A.S. (2004) J. Adolescent Health, 34(5), 420–423.
  • Kao J-H., Chen D-S. (2002) The Lancet Infectious Diseases, 2(7), 395–403.
  • Krahn M., Detsky A.S. (1993) Med. Decis. Making, 13, 4–20.
  • Lahaye D., Baleux C., Strauss P., Van Ganse W. (1987) The Lancet, 330(8556), 441–443.
  • Lavanchy D. (2004) J. Viral Hepat., 11(2), 97–107.
  • Levine R. (2003) In: The Vaccine Book (Bloom B.R., P.H. Lambert, Eds.), Academic Press, San Diego, 23–35.
  • Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., Zhang Y., Liu J., Gong X., Chen Y., Wang F., Zheng H., Wang F., Guo J., Jia Z., Ma J., Wang H., Luo H., Li L., Jin S., Hadler S.C., Wang Y. (2009) J. Infect. Dis., 200, 39–47.
  • Mangtani P., Hall A.J., Normand C.E. (1995) Epidemiol. Community Health, 49, 238–244.
  • Ministry of Health. Positive Dug List Committee and Pricing Committee Registries, www.mg.government.bg (In Bulgarian)
  • Mitkov Tz., Tzenova A., Danchev N., Petrova G. (2004) Arch. Farm., 54, 823–841.
  • NHIF (2010) National Framework Contracts 1989–2010, www.nhif.bg (In Bulgarian)
  • Nichol K.L. (2001) Arch. Intern. Med., 161, 749–759.
  • Plotkin S.L., Plotkin S.A. (2004) In: Vaccines, 4th Ed. (S.A. Plotkin, W.A. Orenstein, Eds.), WB Saunders, Philadelphia, 1–15.
  • Rascati K.L. (2009) Essential of Pharmacoeconomics, Wolters Kluwer, Lippincott Williams & Wilkins, Philadelphia, Baltimore, New York, London, pp. 89–109.
  • U.S. Centers for Disease Control and Prevention (2003) MMWR (Morbidity and Mortality Weekly report), 52(36), 868–870.
  • Van Damme P., Tormans G., Beutels P., Van Doorslaer E. (1992) Vaccine, 13(1),S54–S57.
  • Viral Hepatitis Prevention Board (2011) Meetings and Publications, Presentations, Treatment and laboratory monitoring of chronic hepatitis patients in Bulgaria, March 2011, www.vhph.org
  • WHO (1992) Expanded Programme on Immunization, Global Advisory Group—part I. Wkly Epidemiol. Rec., 67(3), 11–15.
  • Zuckerman J., van Hattum J., Cafferkey M., Gjørup I., Hoel T., Rummukainen M-L., Weiland O. (2007) The Lancet Infectious Diseases, 7(6), 410–419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.